204 related articles for article (PubMed ID: 28012157)
1. Biopsy correlation of surface area vs. single-axis measurements on computed tomography scan of lymph nodes in patients with erythrodermic mycosis fungoides and Sézary syndrome.
Haththotuwa R; Zilinskiene L; Oliff J; Vydianath B; Amel-Kashipaz R; Stevens A; Shah F; Chaganti S; Scarisbrick J
Br J Dermatol; 2017 Sep; 177(3):877-878. PubMed ID: 28012157
[No Abstract] [Full Text] [Related]
2. Histopathologic studies in Sézary syndrome and erythrodermic mycosis fungoides: a comparison with benign forms of erythroderma.
Sentis HJ; Willemze R; Scheffer E
J Am Acad Dermatol; 1986 Dec; 15(6):1217-26. PubMed ID: 2948972
[TBL] [Abstract][Full Text] [Related]
3. Sézary cell count in exfoliative dermatitis.
Duangurai K; Piamphongsant T; Himmungnan T
Int J Dermatol; 1988 May; 27(4):248-52. PubMed ID: 2968960
[TBL] [Abstract][Full Text] [Related]
4. Clinical features of cutaneous T-cell lymphoma.
Abel EA
Dermatol Clin; 1985 Oct; 3(4):647-64. PubMed ID: 2878755
[TBL] [Abstract][Full Text] [Related]
5. Lymph node involvement by mycosis fungoides and Sézary syndrome mimicking angioimmunoblastic T-cell lymphoma.
LeBlanc RE; Lefterova MI; Suarez CJ; Tavallaee M; Kim YH; Schrijver I; Kim J; Gratzinger D
Hum Pathol; 2015 Sep; 46(9):1382-9. PubMed ID: 26193796
[TBL] [Abstract][Full Text] [Related]
6. Diffuse large B-cell lymphoma developing in erythrodermic cutaneous T-cell lymphoma: a case series.
Chan BCY; Stefanato CM; Moonim MT; Morris SL; Fields P; Dasgupta D; Therianou A; Whittaker SJ
Br J Dermatol; 2017 Oct; 177(4):e138-e140. PubMed ID: 28301708
[No Abstract] [Full Text] [Related]
7. [Morphocytochemical characteristics of Sézary cells in the erythrodermic form of mycosis fungoides and Sézary syndrome].
Kozinets GI; Skripkin IuK; Lezvinskaia EM; Dul'tsina SM; Diagileva OA
Sov Med; 1986; (4):43-7. PubMed ID: 2940703
[No Abstract] [Full Text] [Related]
8. Lymph node histopathology in mycosis fungoides and Sézary's syndrome.
Scheffer E; Meijer CJ; Willemze R; van Vloten WA
Curr Probl Dermatol; 1990; 19():105-13. PubMed ID: 2404671
[No Abstract] [Full Text] [Related]
9. Molecular staging of lymph nodes from 60 patients with mycosis fungoides and Sézary syndrome: correlation with histopathology and outcome suggests prognostic relevance in mycosis fungoides.
Fraser-Andrews EA; Mitchell T; Ferreira S; Seed PT; Russell-Jones R; Calonje E; Whittaker SJ
Br J Dermatol; 2006 Oct; 155(4):756-62. PubMed ID: 16965425
[TBL] [Abstract][Full Text] [Related]
10. A High Programmed Cell Death Protein 1 Hormone Receptor Score on Skin Biopsy is Associated with Sézary Syndrome Diagnosis: A Study of 91 Patients with Erythroderma.
Luherne C; Menguy S; Ferte T; Beylot-Barry M; Seneschal J; Milpied B; Vial JP; Gros A; Amintas S; Vergier B; Pham-Ledard A
Acta Derm Venereol; 2022 Sep; 102():adv00773. PubMed ID: 35758515
[TBL] [Abstract][Full Text] [Related]
11. Interleukin 4 and interferon-gamma expression of the dermal infiltrate in patients with erythroderma and mycosis fungoides. An immuno-histochemical study.
Sigurdsson V; Toonstra J; Bihari IC; Bruijnzeel-Koomen CA; van Vloten WA; Thepen T
J Cutan Pathol; 2000 Oct; 27(9):429-35. PubMed ID: 11028812
[TBL] [Abstract][Full Text] [Related]
12. Prognostic factors in erythrodermic mycosis fungoides and the Sézary syndrome.
Kim YH; Bishop K; Varghese A; Hoppe RT
Arch Dermatol; 1995 Sep; 131(9):1003-8. PubMed ID: 7661601
[TBL] [Abstract][Full Text] [Related]
13. Histopathologic staging at initial diagnosis of mycosis fungoides and the Sézary syndrome. Definition of three distinctive prognostic groups.
Sausville EA; Eddy JL; Makuch RW; Fischmann AB; Schechter GP; Matthews M; Glatstein E; Ihde DC; Kaye F; Veach SR
Ann Intern Med; 1988 Sep; 109(5):372-82. PubMed ID: 3408055
[TBL] [Abstract][Full Text] [Related]
14. The MicroRNA Expression Profile Differs Between Erythrodermic Mycosis Fungoides and Sézary Syndrome.
Rittig AH; Lindahl LM; Johansen C; Celis P; Ødum N; Iversen L; Litman T
Acta Derm Venereol; 2019 Nov; 99(12):1148-1153. PubMed ID: 31453630
[TBL] [Abstract][Full Text] [Related]
15. Current problems in mycosis fungoides and Sézary syndrome.
Winkelmann RK; Caro WA
Annu Rev Med; 1977; 28():251-69. PubMed ID: 140621
[No Abstract] [Full Text] [Related]
16. Prognostic factors and evaluation of mycosis fungoides and Sézary syndrome.
Toro JR; Stoll HL; Stomper PC; Oseroff AR
J Am Acad Dermatol; 1997 Jul; 37(1):58-67. PubMed ID: 9216524
[TBL] [Abstract][Full Text] [Related]
17. [Lymph node histopathologic aspects in cutaneous lymphomas of the mycosis fungoides or Sézary syndrome type. Retrospective study of 98 biopsies].
Wechsler J; Diebold J; Gerard-Marchant R
Ann Pathol; 1987; 7(2):122-9. PubMed ID: 3620027
[TBL] [Abstract][Full Text] [Related]
18. Cytologic evaluation of lymphadenopathy associated with mycosis fungoides and Sezary syndrome: role of immunophenotypic and molecular ancillary studies.
Pai RK; Mullins FM; Kim YH; Kong CS
Cancer; 2008 Oct; 114(5):323-32. PubMed ID: 18798522
[TBL] [Abstract][Full Text] [Related]
19. A histologic study of lymph nodes from patients with the Sézary syndrome.
Scheffer E; Meijer CJ; van Vloten WA; Willemze R
Cancer; 1986 Jun; 57(12):2375-80. PubMed ID: 2938724
[TBL] [Abstract][Full Text] [Related]
20. Cytology of the mycosis fungoides and the Sézary syndrome. Correlation between light and electron microscopy.
Orbaneja JG; Yus ES; Diaz-Flores L; Huarte PS
Br J Dermatol; 1972 Aug; 87(2):96-105. PubMed ID: 4262560
[No Abstract] [Full Text] [Related]
[Next] [New Search]